Malignant Neoplasm — Trials

Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

90,685 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 20,116
Recruiting: 10,894
Ph III recruiting: 1,280
Growth YoY: +12%
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (11,163)

clinicaltrialsPublishedShowing 551–600 of 3,046 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03253978	SPORT High-Risk Trial Evaluating SABR in Prostate Cancer(SPORT)	unknown	N/A	40	Belfast Health and Social Care TrustOTHER	1	Sep 7, 2023	clinicaltrials
NCT04593186	Magnifying NBI for Occult NPC	unknown	N/A	246	Chinese University of Hong KongOTHER	1	Sep 7, 2023	clinicaltrials